Back

Long-term effect of biodegradable versus durable polymer drug-eluting stents on neoatherosclerosis among STEMI patients: the international CONNECT randomized controlled intracoronary OCT trial

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Smaller trials, trial updates, and other studies on coronary artery disease and coronary revascularisation Primary Percutaneous Coronary Intervention (PCI) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Jonas Haener

Bern University Hospital, Inselspital, Bern (Switzerland)

3 More presentations in this session

Presentation thumbnail
Assessment of the microvascular resistance reserve for predicting the effect of revascularization in patients with moderate coronary stenoses.
Doctor L. Rasmussen (Herning, DK)
Slides Video
Presentation thumbnail
Glycoprotein IIb/IIIa Inhibitors in patients with acute myocardial infarction and angiographic no-reflow: the randomized REVERSE-FLOW trial
Professor I. Eitel (Luebeck, DE)
Slides Video
Presentation thumbnail
Evaluation of ambulatory electrocardiographic monitoring of patients after high-risk acute coronary syndrome. A randomized trial.
Doctor J. De La Torre Hernandez (Santander, ES)
Slides Video

Access the full session

Session thumbnail
Smaller trials, trial updates, and other studies on coronary artery disease and coronary revascularisation
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Percutaneous intervention is better than surgery in real life for most patients: pro
thumbnail
Congress Presentation
Association of PCI with outcomes in stable coronary artery disease
thumbnail
Congress Presentation
Optimal medical therapy or revascularisation: how new data should change our practice?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources